Premium
Shilpa Medicare plans to sell a stake in its API (Active Pharmaceutical Ingredient) business, its high-revenue generating unit that was spun off into a separate entity this July, said two people aware of the matter. The company has appointed investment bank o3 Capital to manage the stake sale, the people cited ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.